Sven O. Gopel
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
SGLT2 inhibition improves coronary flow velocity reserve and contractility: role of glucagon signaling.
Journal: Cardiovascular diabetology
Published: July 30, 2024
The small molecule SERCA activator CDN1163 increases energy metabolism in human skeletal muscle cells.
Journal: Current research in pharmacology and drug discovery
Published: August 17, 2021
High throughput generation of a resource of the human secretome in mammalian cells.
Journal: New biotechnology
Published: March 12, 2020
Hyperglucagonemia in youth is associated with high plasma free fatty acids, visceral adiposity, and impaired glucose tolerance.
Journal: Pediatric diabetes
Published: November 05, 2018
SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob-/- mice.
Journal: Cardiovascular diabetology
Published: October 04, 2018
Glial cell-line derived neurotrophic factor protects human islets from nutrient deprivation and endoplasmic reticulum stress induced apoptosis.
Journal: Scientific reports
Published: October 26, 2016
Minimized cell usage for stem cell-derived and primary cells on an automated patch clamp system.
Journal: Journal of pharmacological and toxicological methods
Published: February 08, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026